Radiation-induced hyposalivation and its treatment with oral pilocarpine

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 86, Issue 5, 1998, Pages 541-549

  Niedermeier, W ^a,b   Matthaeus, C ^a   Meyer, C ^a   Staar, S ^a   Muller R P ^a   Schulze, H J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b School of Dental Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PILOCARPINE;

ARTICLE; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; MINOR SALIVA GLAND; MUCUS; NONPARAMETRIC TEST; PALATE; PAROTID GLAND; PATHOPHYSIOLOGY; RADIATION EXPOSURE; SALIVA; SECRETION; SKULL IRRADIATION; SQUAMOUS CELL CARCINOMA; STIMULATION; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; CRANIAL IRRADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUCUS; PALATE; PAROTID GLAND; PILOCARPINE; SALIVA; SALIVARY GLANDS, MINOR; SECRETORY RATE; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL; XEROSTOMIA;

EID: 0032198977     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(98)90343-2     Document Type: Article

References (38)

1. Eneroth CM, Henrikson CO, Jakobsson P. Effect of fractionated radiotherapy on salivary gland function. Cancer 1972;30:1147-53.
2. Rubin RL, Doku HC. Therapeutic radiology: the modalities and their effects on oral tissues. J Am Dent Assoc 1976;92:731-9.
3. Shannon IL, Starcke EN, Wescott WB. Effect of radiotherapy on whole saliva flow. J Dent Res 1977;56(Spec Iss):693.
4. Franzen L, Funegard U, Ericson T, Henriksson R. Parotid gland function during and following radiotherapy of malignancies in the head and neck. Eur J Cancer 1992;28:457-62.
5. Funegard U, Franzen L, Ericson T, Henriksson R. Parotid saliva composition during and after irradiation of head and neck cancer. Eur J Cancer B Oral Oncol 1994;30B:230-3.
6. Eneroth CM, Henrikson CO, Jakobsson P. Preirradiation qualities of a parotid gland predicting the grade of functional disturbance by radiotherapy. Acta Otolaryngol (Stockh) 1972;74:436-44.
7. Shannon IL, Trodahl JN, Starcke EN. Radiosensitivity of the human parotid gland. Proc Soc Exp Biol Med 1978;157:50-3.
8. Stephens LC, Ang KK, Schultheiss TE, King GK, Brock WA, Peters LJ. Target cell and mode of radiation injury in rhesus salivary glands. Radiother Oncol 1986;7:165-74.
9. Stephens LC, King GK, Peters LJ, Ang KK, Schultheiss TE, Jardine JH. Acute and late radiation injury in rhesus monkey parotid glands. Am J Pathol 1986;124:469-78.
10. Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 1993;71:1848-51.
11. Epstein JB, Schubert MM. Synergistic effect of sialogogues in management of xerostomia after radiation therapy. Oral Surg Oral Med Oral Pathol 1987;64:179-82.
12. Fox PC, Atkinson JC, Macynski AA, Wolff A, Kung DS, Valdez IH, et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 1991;151:1149-52.
13. Greenspan D, Daniels TE. Effectiveness of pilocarpine in postradiation xerostomia. Cancer 1987;59:1123-5.
14. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, et al. Oral pilocarpine for postradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390-5.
15. LeVeque FG, Montgomery M, Potter D, Zimmer MB, Rieke JW, Steiger BW, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 1993;11:1124-31.
16. Schuller DE, Stevens P, Clausen KP, Olsen J, Gahbauer R, Martin M. Treatment of radiation side-effects with oral pilo-carpine. J Surg Oncol 1989;42:272-6.
17. Rieke JW, Hafermann MD, Johnson JT, LeVeque FG, Iwamoto R, Steiger BW, et al. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiat Oncol Biol Phys 1995;31:661-9.
18. Niedermeier W. Physiologie und Pathophysiologie der kleinen Speicheldrüsen. Deutsche Zeitschrift für Mund-, Kiefer- und Gesichts-Chirurgie 1991;15:6-15.
19. Niedermeier W. Rôles diagnostic et traitement de l'hyposécré-tion des glandes salivaires mineures. Les Cahiers de Prothese 1992;78:9-19.
20. Niedermeier W, Huber M. Quantitative Untersuchungen zur Sekretionsleistung der Gaumenspeicheldrüsen. Deutsche Zahnärztliche Zeitschrift 1989;44:37-40.
21. Niedermeier W, Schuler R. Biometric studies upon medicinal stimulation of human salivary glands. J Dent Res 1992;72(Spec Iss):610.
22. Schaefer ME, Rhodes M, Prince S, Michalek SM, McGhee JR. A Plastic intraoral device for the collection of human parotid saliva. J Dent Res 1977;56:728-33.
23. Kaaber S. Sodium and potassium content in human palatine gland secretion. Arch Oral Biol 1977;22:529-32.
24. Niedermeier W, Schaller K-H, Fischer D. Die Sekretion der Speichel- und Schleimdrüsen im quantitativen Vergleich. Deutsche Zahnärztliche Zeitschrift 1989;44:52-6.
25. National Institutes of Health Consensus Development Panel: Consensus statement: oral complications of cancer therapies. NCI Monogr 1990;9:3.
26. Müller N, Niedermeier W, Bartz K. Morphometrie und Verteilung der Glandulae palatinae bei Prothesenträgern und Nicht-Prothesenträgern. Deutsche Zeitschrift für Mund-, Kiefer-und Gesichts-Chirurgie 1988;12:481-7.
27. Niedermeier W, Hornstein O-P, Müller N, Schaller K-H. Morphologische und funktionelle Merkmale der Gaumenschleimhaut und der Gll. palatinae. Deutsche Zahnärztliche Zeitschrift 1990;45:27-31.
28. Rauch S. Physiologie und Pathologie der Regulationen der Speicheldrüsentätigkeit. Deutsche Zahnärztliche Zeitschrift 1961;16:153-60.
29. Junglee D, Katrak A, Mohiuddin J, Blacklock H, Prentice HG, Dandona P. Salivary amylase and pancreatic enzymes in serum after total body irradiation. Cin Chem 1986;32:609-10.
30. Rubin P, Casarett G. A direction for clinical radiation pathology: the tolerance dose. Front Radiat Ther Oncol 1972;6:1-16.
31. Munro TR. The site of the target region for radiation-induced mitotic delay in cultured mammalian cells. Radiat Res 1970;44:748-57.
32. 2 arrest studied by the induction of premature chromosome condensation following cell fusion. Int J Radiat Biol 1978;34:349-57.
33. Alper T. The role of membrane damage in radiation-induced cell death. Adv Exp Med Biol 1977;84:139-65.
34. Fox PC. Salivary function in disease. J Dent Res 1993;72(Spec Iss):190.
35. Cheng VST, Downs J, Herbert D, Aramany M. The function of the parotid gland following radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 1981;7:253-8.
36. Mira JG, Fullerton GD, Wescott WB. Correlation between initial salivary flow rate and radiation dose in the production of xerostomia. Acta Rad Oncol 1982;21:151-4.
37. Makkonen TA, Nordman E. Estimation of long-term salivary gland damage induced by radiotherapy. Acta Oncol 1987;26:307-12.
38. Mandel ID, Katz R, Zengo A, Kutscher Ah, Greenberg RA, Katz S, et al.. The effect of pharmacologic agent on salivary secretion and composition in man. J Oral Ther Pharmacol 1968;4:192-9.